Windgap Medical Selected to Collaborate with Novo Nordisk Bio Innovation Hub
Windgap's Compact Epinephrine Autoinjector (Not approved for sale in the US)
Boston, MA – May 16, 2024 – Windgap Medical, a leader in patient-centric and innovative drug delivery platforms, is thrilled to announce its selection for collaboration with the Novo Nordisk Bio-Innovation Hub through its prestigious Co-Creation Greenhouse Program.
Windgap’s dual-chamber delivery technology revolutionizes the capabilities of both the device and the medicine it contains by stabilizing and simplifying treatment options. This partnership with Novo Nordisk will further assess and develop Windgap’s dual-chamber autoinjector for automatic reconstitution and administration of diabetes and obesity therapeutics.
"This joining of forces is a significant milestone in our mission to advance patient-centric solutions and long-acting therapies,” said Jason Durkin, Vice President of Supply Chain at Windgap Medical. “Together, we are making strides towards a future where managing diabetes and weight loss is more convenient, sustainable, and effective than ever before."
The Co-Creation Greenhouse Program, renowned for fostering innovation and collaboration, provides an invaluable platform for Windgap Medical and Novo Nordisk to combine their expertise and drive forward the development of groundbreaking solutions in the healthcare industry.
ABOUT WINDGAP MEDICAL
Based in Boston, Massachusetts, Windgap Medical is a multiplatform drug delivery company specializing in innovative solutions for difficult-to-mix, co-delivered, high-viscosity, and large-volume drug therapies. With a focus on patient-centric design and sustainable solutions, Windgap is committed to injecting simplicity into complex drug delivery for a faster path to market—and better, sustainable patient outcomes.
About Novo Nordisk
Founded in 1923, Novo Nordisk is a global healthcare company with over 100 years of innovation and leadership in diabetes care. Novo Nordisk aims to drive change to defeat diabetes and other serious chronic conditions by pioneering scientific breakthroughs, expanding access to therapies, and working to prevent and ultimately cure disease.
FOR QUESTIONS, CONTACT:
Aaron Mann
Windgap Medical, Inc.
(339) 232-7759
press@windgapmedical.com